Your browser doesn't support javascript.
loading
Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma.
Mateos, María-Victoria; Chari, Ajai; Usmani, Saad Z; Goldschmidt, Hartmut; Weisel, Katja; Qi, Keqin; Londhe, Anil; Nair, Sandhya; Lin, Xiwu; Pei, Lixia; Ammann, Eric; Kobos, Rachel; Smit, Jennifer; Parekh, Trilok; Marshall, Alexander; Slavcev, Mary; Moreau, Philippe.
Afiliación
  • Mateos MV; University Hospital of Salamanca/IBSAL/CIC, Salamanca, Spain. Electronic address: mvmateos@usal.es.
  • Chari A; Mount Sinai School of Medicine, New York, NY.
  • Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Goldschmidt H; University Hospital Heidelberg, Heidelberg, Germany.
  • Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Qi K; Janssen Research & Development, Titusville, NJ.
  • Londhe A; Janssen Research & Development, Titusville, NJ.
  • Nair S; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Lin X; Janssen Research & Development, Spring House, PA.
  • Pei L; Janssen Research & Development, Raritan, NJ.
  • Ammann E; Janssen Global Services, Raritan, NJ.
  • Kobos R; Janssen Research & Development, Raritan, NJ.
  • Smit J; Janssen Research & Development, Spring House, PA.
  • Parekh T; Janssen Research & Development, Bridgewater, NJ.
  • Marshall A; Janssen Global Services, Raritan, NJ.
  • Slavcev M; Janssen Global Services, Raritan, NJ.
  • Moreau P; University Hospital Hôtel-Dieu, Nantes, France.
Clin Lymphoma Myeloma Leuk ; 23(5): 385-393, 2023 05.
Article en En | MEDLINE | ID: mdl-36967244

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article